Low Molecular Weight Heparins in Phlebological Practice: Focus on Parnaparin
Literature review deals with pharmacology and clinical use of low molecular weight heparin parnaparin, intended for prevention and treatment of venous thromboembolic complications, acute superficial vein thrombosis, as well as severe forms of chronic venous insufficiency.